Key Metrics
CiteScore 

4
Impact Factor 

< 5
SJR 

Q2Epidemiology

SNIP 

1.03
Recommended pre-submission checks
Powered by 

Topics Covered on Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1992 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacoepidemiology and Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmacoepidemiology and Drug Safety
Pharmacological Therapy in Patients With Gender Dysphoria: A Cohort Study in the Lazio Region, Italy.
- 1 Aug 2026
- Pharmacoepidemiology and drug safety
Prenatal Exposure to Modafinil and the Risk of Major Congenital Anomalies and Other Adverse Neonatal and Pediatric Outcomes
- 1 Aug 2026
- Pharmacoepidemiology and Drug Safety
Real-World Data for Safety Studies: Challenges and Opportunities From the Italian Multiple Sclerosis and Related Disorders Register.
- 1 Aug 2026
- Pharmacoepidemiology and drug safety
Comment on 'Comparative Effectiveness and Safety of Three Oral Antihypertensive Therapies on Maternal and Infant Outcomes in a California Medicaid Population, 2016-2020'.
- 1 Aug 2026
- Pharmacoepidemiology and drug safety
Climate Change and Medications: Implications for Clinical Practice, Healthcare Sustainability, and Pharmacoepidemiology
- 31 Jul 2026
- Pharmacoepidemiology and Drug Safety
DU\u2010Vigilance; Capturing Unsuspected Problems in Drug Utilization
- 30 Jul 2026
- Pharmacoepidemiology and Drug Safety
Pharmacological Therapy in Patients With Gender Dysphoria: A Cohort Study in the Lazio Region, Italy.
- 1 Aug 2026
- Pharmacoepidemiology and drug safety
Prenatal Exposure to Modafinil and the Risk of Major Congenital Anomalies and Other Adverse Neonatal and Pediatric Outcomes
- 1 Aug 2026
- Pharmacoepidemiology and Drug Safety
Real-World Data for Safety Studies: Challenges and Opportunities From the Italian Multiple Sclerosis and Related Disorders Register.
- 1 Aug 2026
- Pharmacoepidemiology and drug safety
Comment on 'Comparative Effectiveness and Safety of Three Oral Antihypertensive Therapies on Maternal and Infant Outcomes in a California Medicaid Population, 2016-2020'.
- 1 Aug 2026
- Pharmacoepidemiology and drug safety
Climate Change and Medications: Implications for Clinical Practice, Healthcare Sustainability, and Pharmacoepidemiology
- 31 Jul 2026
- Pharmacoepidemiology and Drug Safety
DU\u2010Vigilance; Capturing Unsuspected Problems in Drug Utilization
- 30 Jul 2026
- Pharmacoepidemiology and Drug Safety